SUSMED,Inc. (TYO:4263)
Japan flag Japan · Delayed Price · Currency is JPY
246.00
-4.00 (-1.60%)
Nov 18, 2026, 10:49 AM JST

SUSMED,Inc. Financials Overview

Millions JPY. Fiscal year is Jul - Jun.

Revenue & Profits

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
679497462342530316
Revenue Growth
42.95%7.58%35.09%-35.47%67.72%174.78%
Gross Profit
658479450330522305
Operating Income
-259-330-300-365-48-230
Net Income
-465-382-298-357-50-233
Earnings Per Share
-27.58-22.67-17.75-21.39-3.05-15.87
EPS Growth
------

Revenue by Segment

Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingJun '24 Jun '23 Jun '22 Jun '21 Jun '20
Digital Therapeutics Product
200400200--
Digital Therapeutics Platform
142.58130.65116.87115.4934.89

Cash & Debt

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Cash (Debt)
3,9523,6984,3984,8465,0484,904
Net Cash Growth
-5.16%-15.92%-9.25%-4.00%2.94%201.60%
Net Cash Per Share
234.39219.49261.90290.30307.76333.99
Cash & Investments
3,9523,6984,3984,8465,0484,904

Cash Flow & CapEx

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
--474-432-230100-165
Capital Expenditures
--74-4-3-6-12
Free Cash Flow
--548-436-23394-177
Free Cash Flow Growth
------

Margins

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
96.91%96.38%97.40%96.49%98.49%96.52%
Operating Margin
-38.14%-66.40%-64.94%-106.73%-9.06%-72.78%
Pretax Margin
-68.04%-76.26%-64.29%-104.09%-9.25%-73.73%
Profit Margin
-68.48%-76.86%-64.50%-104.39%-9.43%-73.73%
FCF Margin
--110.26%-94.37%-68.13%17.74%-56.01%

Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingNov '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
P/FCF Ratio
----314.33-
PS Ratio
6.1929.3322.2429.3755.7546.54